Placebo News and Research

RSS

Transplanting gut bacteria from stress-vulnerable rats alters behavior, brain inflammation in recipient

Scientists have shown that transplanting gut bacteria, from an animal that is vulnerable to social stress to a non-stressed animal, can cause vulnerable behavior in the recipient.

7 May 2019

New drug successfully lowers levels of toxic protein that causes Huntington disease

An international clinical trial has found that a new drug for Huntington disease is safe, and that treatment with the drug successfully lowers levels of the abnormal protein that causes the debilitating disease in patients.

7 May 2019

Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder.

3 May 2019

Targeting antidiuretic hormone vasopressin shows promise for autism

Autism is a complex neurodevelopmental disorder with no known drug treatment up until now. Researchers have finally found tweaking certain hormones could help patients with autism. There were two independent clinical trials including children and adults with autism that altered the effects of the hormone vasopressin and to assess the effects on social functioning.

2 May 2019

Protein supplements containing BCAA may have ‘detrimental effects’ on health and lifespan

New research suggests that BCAAs in the form of pre-mixed protein powders, shakes and supplements may do more harm to health than good.

1 May 2019

Diabetes drug could help with smoking cessation

Phillip Robinson has gone from 10 cigarettes a day to one or two every other day after enrolling in a smoking cessation clinical trial launched by researchers at The University of Texas Health Science Center at Houston

30 Apr 2019

Study results of a potential drug to treat Type 2 diabetes in children announced

Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, Md. The New England Journal of Medicine also published the findings.

29 Apr 2019

Intensive blood pressure treatment benefits people with type 2 diabetes regardless of cardiovascular risk

People with type 2 diabetes who received intensive treatment to keep their blood pressure levels at 130/80 mm/Hg or below had fewer heart attacks, strokes and other diabetes complications, according to a study published in the American Heart Association's journal Hypertension.

29 Apr 2019

Peppermint oil helps people with non-cardiac chest pain and difficulty swallowing

Imagine that while eating a delicious meal at your favorite restaurant, your joy is cut short because of difficulty swallowing your food, followed by chest pain.

27 Apr 2019

FDA approves new treatment for children with lupus

The U.S. Food and Drug Administration today approved Benlysta (belimumab) intravenous infusion for treatment of children with systemic lupus erythematosus – often referred to as simply "lupus" – a serious chronic disease that causes inflammation and damage to various body tissues and organs.

27 Apr 2019

Peanut allergy tolerance treatment may increase the risk of anaphylaxis

Treating children who have a peanut allergy by gradually exposing them to increasing levels of peanut extract may actually increase their risk of allergic attacks, warn researchers.

26 Apr 2019

Psychologists study how application of cortisol affects exposure therapy for anxiety disorders

Bochum-based psychologists have studied how the application of the stress hormone cortisol affects exposure therapy for anxiety disorders.

25 Apr 2019

Using blood thinners in heart failure patients associated with reduced risk of thromboembolic events

Researchers at University of California San Diego School of Medicine found that using blood thinners in patients with worsening heart failure, coronary artery disease or irregular heart rhythms was associated with a 17 percent reduced risk of thromboembolic events, such as stroke and heart attack.

25 Apr 2019

FDA authorizes marketing of first medical device to treat ADHD

The U.S. Food and Drug Administration today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder.

22 Apr 2019

Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients

The commonly used diabetes drug metformin could reverse the harmful thickening of heart muscle that leads to cardiovascular disease, according to a study at the University of Dundee.

17 Apr 2019

Magic mouthwash effectively reduces mouth sore pain caused by radiation therapy

"Magic mouthwash," an oral rinse containing diphenhydramine, lidocaine and antacids, significantly reduced pain from oral mucositis, mouth sores, in patients receiving radiation therapy for cancers of the head and neck when compared to plaecbo.

16 Apr 2019

Drug lowers kidney failure risk in diabetic patients, study finds

A new landmark clinical trial shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.

15 Apr 2019

Rheumatoid arthritis patients likely to experience cardiovascular benefits from statins

Results from a large clinical trial indicate that patients with rheumatoid arthritis are likely to experience the same level of cardiovascular benefits from statins as other individuals, without additional risks.

15 Apr 2019

Brain training to strengthen the brain's neural network

A new study reveals that less than an hour of training the brain could help strengthen the neural connections of the brain. This study could help develop new treatment and management strategies for progressive neurodegenerative disorders such as stroke and Parkinson’s believe the researchers.

15 Apr 2019

Less than one hour of brain training leads to strengthening of neural connections

Less than one hour of brain training with neurofeedback leads to a strengthening of neural connections and communication among brain areas.

15 Apr 2019

Placebo News and Research

Transplanting gut bacteria from stress-vulnerable rats alters behavior, brain inflammation in recipient

New drug successfully lowers levels of toxic protein that causes Huntington disease

Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

Targeting antidiuretic hormone vasopressin shows promise for autism

Protein supplements containing BCAA may have ‘detrimental effects’ on health and lifespan

Diabetes drug could help with smoking cessation

Study results of a potential drug to treat Type 2 diabetes in children announced

Intensive blood pressure treatment benefits people with type 2 diabetes regardless of cardiovascular risk

Peppermint oil helps people with non-cardiac chest pain and difficulty swallowing

FDA approves new treatment for children with lupus

Peanut allergy tolerance treatment may increase the risk of anaphylaxis

Psychologists study how application of cortisol affects exposure therapy for anxiety disorders

Using blood thinners in heart failure patients associated with reduced risk of thromboembolic events

FDA authorizes marketing of first medical device to treat ADHD

Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients

Magic mouthwash effectively reduces mouth sore pain caused by radiation therapy

Drug lowers kidney failure risk in diabetic patients, study finds

Rheumatoid arthritis patients likely to experience cardiovascular benefits from statins

Brain training to strengthen the brain's neural network

Less than one hour of brain training leads to strengthening of neural connections

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News